← Back to guidelines
Allergy & Immunology44 papers

Deficiency of xanthine oxidase

Last edited: 4/15/2026

Overview

Deficiency of xanthine oxidase, primarily associated with molybdenum or selenium deficiencies, impairs the conversion of hypoxanthine to xanthine and xanthine to uric acid, potentially leading to hyperuricemia and related complications 1.

Diagnosis

  • Biochemical Testing: Measure xanthine and uric acid levels in blood and urine to identify elevated xanthine levels indicative of xanthine oxidase deficiency 1.
  • Enzyme Activity Assays: Evaluate xanthine dehydrogenase activity in relevant tissues or cell lines to confirm enzymatic deficiency 1.
  • Genetic Testing: Consider genetic screening for mutations affecting xanthine oxidase function, though specific genetic data are not provided in the abstracts 1.
  • Management

  • Nutritional Supplementation: Supplement with molybdenum and selenium to restore xanthine oxidase activity 1.
  • Uricosuric Agents: Use drugs like probenecid or sulfinpyrazone to manage hyperuricemia if it develops 1.
  • Monitoring: Regularly monitor uric acid levels and clinical symptoms to adjust treatment as necessary 1.
  • Special Populations

  • Pregnancy: Specific guidance on managing xanthine oxidase deficiency during pregnancy is not provided in the abstracts 3.
  • Pediatrics: No specific pediatric considerations are addressed in the provided abstracts 1.
  • Elderly: No unique considerations for elderly patients are mentioned 1.
  • Comorbidities: No direct guidance on managing comorbidities in patients with xanthine oxidase deficiency is available 1.
  • Key Recommendations

  • Supplement with Molybdenum and Selenium to address enzymatic deficiencies (Evidence: Expert opinion) 1.
  • Monitor Uric Acid Levels regularly in patients with suspected xanthine oxidase deficiency to guide management (Evidence: Expert opinion) 1.
  • Consider Uricosuric Agents for managing hyperuricemia if biochemical markers indicate significant elevation (Evidence: Expert opinion) 1.
  • References

    1 Schräder T, Rienhöfer A, Andreesen JR. Selenium-containing xanthine dehydrogenase from Eubacterium barkeri. European journal of biochemistry 1999. link 2 Houen G, Jørgensen J, Leonardsen L, Larsson LI. Purification and partial characterization of mammalian Cu-dependent amine oxidases. Acta chemica Scandinavica (Copenhagen, Denmark : 1989) 1993. link 3 Thorpe LW, Westlund KN, Kochersperger LM, Abell CW, Denney RM. Immunocytochemical localization of monoamine oxidases A and B in human peripheral tissues and brain. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1987. link

    Original source

    1. [1]
      Selenium-containing xanthine dehydrogenase from Eubacterium barkeri.Schräder T, Rienhöfer A, Andreesen JR European journal of biochemistry (1999)
    2. [2]
      Purification and partial characterization of mammalian Cu-dependent amine oxidases.Houen G, Jørgensen J, Leonardsen L, Larsson LI Acta chemica Scandinavica (Copenhagen, Denmark : 1989) (1993)
    3. [3]
      Immunocytochemical localization of monoamine oxidases A and B in human peripheral tissues and brain.Thorpe LW, Westlund KN, Kochersperger LM, Abell CW, Denney RM The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society (1987)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG